#ELEVIDYS_therapy
LightNews LightNews
newsen.bsky.social
Investors Invited to Lead Class Action Suit Against Sarepta Therapeutics with Schall Law Firm#United_States#Los_Angeles#Schall_Law_Firm#Sarepta_Therapeutics#ELEVIDYS_therapy
Investors Invited to Lead Class Action Suit Against Sarepta Therapeutics with Schall Law Firm
Sarepta Therapeutics faces a class action lawsuit for false statements regarding its ELEVIDYS therapy. Discover your rights as an investor.
third-news.com
August 21, 2025 at 9:07 AM
newsen.bsky.social
Sarepta Therapeutics Shareholders Urged to Join Class Action Lawsuit After Sectioned Allegations#United_States#New_York#Securities_Class_Action#Sarepta_Therapeutics#ELEVIDYS_therapy
Sarepta Therapeutics Shareholders Urged to Join Class Action Lawsuit After Sectioned Allegations
Sarepta Therapeutics shareholders are encouraged to join a class action lawsuit due to allegations of misleading statements surrounding ELEVIDYS gene therapy. Act by August 25, 2025.
third-news.com
August 18, 2025 at 1:05 PM
newsen.bsky.social
Sarepta Therapeutics Shareholders Urged to Lead Securities Lawsuit Against the Company#USA#DJS_Law_Group#Eastchester#Sarepta_Therapeutics#ELEVIDYS_therapy
Sarepta Therapeutics Shareholders Urged to Lead Securities Lawsuit Against the Company
Sarepta Therapeutics investors can join a class action lawsuit for alleged misinformation on the Company's ELEVIDYS therapy. Contact DJS Law Group before the deadline.
third-news.com
July 21, 2025 at 3:16 PM
newsen.bsky.social
Shareholders of Sarepta Therapeutics Urged to Lead Class Action Lawsuit Ahead of Deadline#United_States#DJS_Law_Group#Eastchester#Sarepta_Therapeutics#ELEVIDYS_therapy
Shareholders of Sarepta Therapeutics Urged to Lead Class Action Lawsuit Ahead of Deadline
Investors in Sarepta Therapeutics are reminded about a key class action lawsuit against the company. Shareholders should act quickly due to the approaching deadline.
third-news.com
July 14, 2025 at 2:26 PM